Protein diversity, type 2 diabetes, and effect modifiers: a multi-country prospective study [0.03%]
蛋白质多样性、2型糖尿病及效应修饰因子：一项跨国前瞻性研究
Hadis Mozaffari,Fumiaki Imamura,Rachel A Murphy et al.
Hadis Mozaffari et al.
Background: Dietary diversity may affect type 2 diabetes (T2D) but no studies have examined protein diversity by source. We examined five diversity scores and the 10-year risk of T2D and effect modification. ...
Multicenter Study
International journal of epidemiology. 2025 Apr 12;54(3):dyaf057. DOI:10.1093/ije/dyaf057 2025
Identification of α2-macroglobulin as a biomarker for type 2 diabetes in human serum [0.03%]
人血清中α2-巨球蛋白作为2型糖尿病生物标志物的鉴定
Mingjie Wang,Limei He,Yuandi Chang et al.
Mingjie Wang et al.
Objectives: This study aimed to determine potential serum biomarkers of type 2 diabetes (T2DM) through proteomic data analysis and protein association assessment. ...
Subclassification of Type 2 Diabetes Paves the Way for Personalized Outcome Prediction and Patient Management [0.03%]
2型糖尿病的亚分类为个性化预后预测和患者管理铺平了道路
Ruhan Wei,Jessica M Colón-Franco
Ruhan Wei
[GLP-1 agonists : cardio-renal benefit in type 2 diabetic patient] [0.03%]
[ GLP-1 激动剂与 2 型糖尿病患者的心肾获益 ]
Juliette Levy,Karim Gariani
Juliette Levy
GLP-1 analogs have revolutionized the management of type 2 diabetes, providing metabolic and cardiovascular benefits independent of glycemic control. In addition to promoting weight loss and improving endothelial function, they reduce the r...
The efficacy of PRECEDE-PROCEED model-based interventions on HbA1c and self-management in type 2 diabetes patients: a systematic review and meta-analysis [0.03%]
基于PRECEDE-PROCEED模型的干预措施对2型糖尿病患者HbA1c和自我管理的效果：系统评价和meta分析
Yan Tang,Kim Lam Soh,Wan Ying Gan et al.
Yan Tang et al.
Background: Type 2 diabetes is a global public health challenge characterized by high prevalence and poor self-management outcomes. The PRECEDE-PROCEED model is a well-known conceptual widely used to promote health in chr...
Meta-Analysis
BMC public health. 2025 May 29;25(1):1980. DOI:10.1186/s12889-025-23073-9 2025
Glucagon-Like Peptide-1 Use and Healthcare Resource Utilization for Depression and Anxiety Among Adults with Type 2 Diabetes: 2019 to 2023 [0.03%]
GLP-1的使用与2型糖尿病成人抑郁和焦虑的医疗资源利用：2019至2023年
Duy Do,Tiffany Lee,Angela Inneh et al.
Duy Do et al.
Mental health disorders, including depression and anxiety, are common comorbidities in individuals with type 2 diabetes mellitus (T2DM), contributing to increased healthcare resource utilization (HCRU) and the financial burden of the diseas...
Redefining Liver Fibrosis Risk Assessment in Indians with Type 2 Diabetes: New FIB-4 Score Cutoff for Optimizing Sequential Assessment with Transient Elastography [0.03%]
印度2型糖尿病人群肝纤维化风险评估的新标准：优化瞬时弹性成像序贯检测的FIB-4评分截断值重新定义
Rajat Deb,Soumik Goswami,Nilanjan Sengupta et al.
Rajat Deb et al.
Introduction: Liver fibrosis in metabolic dysfunction-associated steatotic liver disease (MASLD) is strongly related to hepatic and extrahepatic outcomes. Clinically Significant Liver Fibrosis (CSLF) screening using FIB-4...
Predictive factors of hypoglycemia in type 2 diabetes: a prospective study using machine learning [0.03%]
二型糖尿病患者低血糖预测因素：一种利用机器学习的前瞻性研究
Motahare Shabestari,Akram Mehrabbeik,Sebastiano Barbieri et al.
Motahare Shabestari et al.
Hypoglycemia is a serious complication in individuals with type 2 diabetes mellitus. Identifying who is most at risk remains challenging due to the non-linear relationships between hypoglycemia and its associated risk factors. The objective...
Immunocytes Play a Crucial Role as Mediators in the Protective Effects of D-β-Hydroxybutyrate Dehydrogenase 1 against Type 2 Diabetes Mellitus: A Mendelian Randomization Study [0.03%]
D-β-羟丁酸脱氢酶1通过免疫细胞在2型糖尿病保护作用中的介导效应：一项孟德尔随机化研究
Yi-Ying Liu,Yue-Yang Zhang,Qin Wan
Yi-Ying Liu
Background: Observational studies suggest an association between the immune system and type 2 diabetes. The present study sought to ascertain the causal relationship between BDH1 and type 2 diabetes and investigate whethe...
耗时 0.11836 秒，为您在
48206918
条记录里面共找到 3585 篇文章 [XML]